Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, ARS Pharmaceuticals Inc’s stock clocked out at $12.01, up 5.72% from its previous closing price of $11.36. In other words, the price has increased by $5.72 from its previous closing price. On the day, 1.8 million shares were traded. SPRY stock price reached its highest trading level at $12.085 during the session, while it also had its lowest trading level at $11.01.
Ratios:
To gain a deeper understanding of SPRY’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.50 and its Current Ratio is at 12.54. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On August 13, 2024, Raymond James Upgraded its rating to Strong Buy which previously was Outperform and also upped its target price recommendation from $18 to $22.
Leerink Partners reiterated its Outperform rating for the stock on August 12, 2024, while the target price for the stock was revised from $19 to $20.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 06 ’25 when Shawver Laura sold 50,000 shares for $11.10 per share. The transaction valued at 555,065 led to the insider holds 210,346 shares of the business.
Shawver Laura bought 50,000 shares of SPRY for $555,065 on Jan 06 ’25. On Dec 17 ’24, another insider, Tanimoto Sarina, who serves as the CHIEF MEDICAL OFFICER of the company, sold 100,000 shares for $11.67 each. As a result, the insider received 1,167,100 and left with 1,098,499 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SPRY now has a Market Capitalization of 1167197952 and an Enterprise Value of 960836288. For the stock, the TTM Price-to-Sale (P/S) ratio is 454.16 while its Price-to-Book (P/B) ratio in mrq is 5.81. Its current Enterprise Value per Revenue stands at 374.157 whereas that against EBITDA is -15.896.
Stock Price History:
Over the past 52 weeks, SPRY has reached a high of $18.51, while it has fallen to a 52-week low of $5.75. The 50-Day Moving Average of the stock is -8.11%, while the 200-Day Moving Average is calculated to be 3.61%.
Shares Statistics:
It appears that SPRY traded 1.23M shares on average per day over the past three months and 1344410 shares per day over the past ten days. A total of 97.15M shares are outstanding, with a floating share count of 51.12M. Insiders hold about 47.40% of the company’s shares, while institutions hold 42.21% stake in the company. Shares short for SPRY as of 1735603200 were 13675218 with a Short Ratio of 11.16, compared to 1732838400 on 13629789. Therefore, it implies a Short% of Shares Outstanding of 13675218 and a Short% of Float of 26.459998000000002.
